UNSPSC 51282102: Amantocillin

This classification denotes a penicillin antibiotic with the molecular formula C19H27N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, GV5ZHU20H9 chemically known as 6-(3-amino-1-adamantanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as amantocillin, which bears US NIH Compound Identifier 168908. European Medicines Agency schedules Amantocillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05391MIG.

UNSPSC 51282102 Amantocillin is a Commodity code nominally designating a specific antibiotic product, but recent state and local solicitations tagged under this code do not center on amantocillin itself. Instead, purchasing activity shows state and local governments acquiring a broader range of pharmaceutical and medical supply products — naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter (OTC) products, medical and first aid supplies for emergency response, and exploratory direct-to-manufacturer prescription programs. The actual procurement scope reflects health departments, fire departments, and pharmacy benefit administrators sourcing medications, emergency medical consumables, and prescription fulfillment infrastructure rather than a single antibiotic formulation. Issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), city fire departments (Tampa Fire Department), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving multiple states and local jurisdictions). The fragmented issuing-body mix suggests that pharmaceutical and medical supply procurement occurs across diverse public health and emergency services verticals rather than concentrating in a single agency type.

Recent activity spans Florida, Texas, Minnesota, and multi-state cooperative purchasing platforms. A representative opportunity is Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023), soliciting 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building on a two-year contract with one-year renewal option. The City of Tampa issued IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies to the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a small-local-business-enterprise (SLBE) set-aside including a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers, with awards effective July 1, 2026. The Texas Health and Human Services Commission issued an exploratory RFI (HHS0017013, response due April 3, 2026) to gather vendor capacity information on direct-to-manufacturer prescription programs, signaling early-stage procurement planning rather than immediate contracting.